Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging

2.50
Hdl Handle:
http://hdl.handle.net/10541/70476
Title:
Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging
Authors:
Jackson, Alan; O'Connor, James P B; Parker, Geoff J M; Jayson, Gordon C ( 0000-0002-8515-8944 )
Abstract:
This article reviews the application of dynamic contrast-enhanced magnetic resonance imaging in both clinical studies and early-phase trials of angiogenesis inhibitors. Emphasis is placed on how variation in image acquisition and analysis affects the meaning and use of derived variables. We then review the potential for future developments, with particular reference to the application of dynamic contrast-enhanced magnetic resonance imaging to evaluate the heterogeneity of tumor tissues.
Affiliation:
Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom.
Citation:
Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. 2007, 13 (12):3449-59 Clin. Cancer Res.
Journal:
Clinical Cancer Research
Issue Date:
15-Jun-2007
URI:
http://hdl.handle.net/10541/70476
DOI:
10.1158/1078-0432.CCR-07-0238
PubMed ID:
17575207
Type:
Article
Language:
en
ISSN:
1078-0432
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorJackson, Alan-
dc.contributor.authorO'Connor, James P B-
dc.contributor.authorParker, Geoff J M-
dc.contributor.authorJayson, Gordon C-
dc.date.accessioned2009-06-15T12:26:19Z-
dc.date.available2009-06-15T12:26:19Z-
dc.date.issued2007-06-15-
dc.identifier.citationImaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. 2007, 13 (12):3449-59 Clin. Cancer Res.en
dc.identifier.issn1078-0432-
dc.identifier.pmid17575207-
dc.identifier.doi10.1158/1078-0432.CCR-07-0238-
dc.identifier.urihttp://hdl.handle.net/10541/70476-
dc.description.abstractThis article reviews the application of dynamic contrast-enhanced magnetic resonance imaging in both clinical studies and early-phase trials of angiogenesis inhibitors. Emphasis is placed on how variation in image acquisition and analysis affects the meaning and use of derived variables. We then review the potential for future developments, with particular reference to the application of dynamic contrast-enhanced magnetic resonance imaging to evaluate the heterogeneity of tumor tissues.en
dc.language.isoenen
dc.subjectCanceren
dc.subject.meshAngiogenesis Inhibitors-
dc.subject.meshAnimals-
dc.subject.meshClinical Trials as Topic-
dc.subject.meshHumans-
dc.subject.meshImage Enhancement-
dc.subject.meshImage Processing, Computer-Assisted-
dc.subject.meshMagnetic Resonance Imaging-
dc.subject.meshNeoplasms-
dc.subject.meshNeovascularization, Pathologic-
dc.titleImaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imagingen
dc.typeArticleen
dc.contributor.departmentImaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom.en
dc.identifier.journalClinical Cancer Researchen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.